GIPLOTCSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Global Innovative Platforms Inc.

Financials through Q1 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Aug 14, 2026

$0.50+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Global Innovative Platforms reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Global Innovative Platforms's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Global Innovative Platforms's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2000 reverse split on Dec 30, 2020
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GIPL.

Operating margin-2157.4% · median -13347.7%

Net margin-2157.4% · median -7214.1%

Company	Revenue	Growth
PAVM	$112.00K	-89.0%
RDGL	$99.10K	+91.5%
GIPL	$30.00K	–
GUTS	–	–
PFSA	–	–
QTEX	–	–

Company

Exchange: OTC
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: September 30
Auditor: CNGSN & Associates LLP
SEC CIK: 1837774

Advertisement
300 × 250